Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Wake Forest University Health Sciences
Stanford University
INSYS Therapeutics Inc